• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

[外用非甾体抗炎药:无效还是未得到充分重视?]

[Topical NSAIDs: ineffective or undervalued?].

作者信息

van Herwaarden Noortje, van den Elsen Geke A H, de Jong Ingrid C A, Kramers C Kees, Kloppenburg Margreet, van den Bemt Bart J F

机构信息

Radboudumc, Nijmegen. Afd. Reumatische Ziekten.

Contact: Noortje van Herwaarden (

出版信息

Ned Tijdschr Geneeskd. 2021 May 19;165:D5317.

PMID:34346575
Abstract

Topical NSAIDs are currently recommended in several national and international guidelines for knee osteoarthritis, hand osteoarthritis and acute musculoskeletal pain. However, there is still widespread skepticism about the effectiveness of this treatment. This article discusses different reasons for this skepticism, a short summary of the pharmacokinetics and pharmacodynamics of topical NSAIDs and an overview of available evidence regarding efficacy and safety. Based on this evidence topical NSAIDs have a clear place in the treatment of knee and hand osteoarthritis and acute musculoskeletal pain. Due to less systemic side effects they should be recommended before an oral NSAID is considered. Topical NSAIDs might even be an option for patients with contra-indications for oral NSAIDs. There is a large variety of available topical NSAIDs. Of the available topical NSAIDs in the Netherlands, diclofenac gel seems the most sensible choice.

摘要

目前,多种国内外指南推荐使用外用非甾体抗炎药治疗膝关节骨关节炎、手部骨关节炎和急性肌肉骨骼疼痛。然而,对于这种治疗方法的有效性仍普遍存在怀疑。本文讨论了产生这种怀疑的不同原因,简要总结了外用非甾体抗炎药的药代动力学和药效学,并概述了有关其疗效和安全性的现有证据。基于这些证据,外用非甾体抗炎药在治疗膝关节和手部骨关节炎以及急性肌肉骨骼疼痛方面具有明确的地位。由于其全身副作用较少,在考虑使用口服非甾体抗炎药之前应推荐使用外用非甾体抗炎药。对于有口服非甾体抗炎药禁忌证的患者,外用非甾体抗炎药甚至可能是一种选择。市面上有多种外用非甾体抗炎药可供选择。在荷兰现有的外用非甾体抗炎药中,双氯芬酸凝胶似乎是最合理的选择。

相似文献

1
[Topical NSAIDs: ineffective or undervalued?].[外用非甾体抗炎药:无效还是未得到充分重视?]
Ned Tijdschr Geneeskd. 2021 May 19;165:D5317.
2
Topical therapy for osteoarthritis: clinical and pharmacologic perspectives.骨关节炎的局部治疗:临床与药理学视角
Postgrad Med. 2009 Mar;121(2):139-47. doi: 10.3810/pgm.2009.03.1986.
3
Efficacy and safety of topical NSAIDs in the management of osteoarthritis: Evidence from real-life setting trials and surveys.局部用非甾体抗炎药治疗骨关节炎的疗效与安全性:来自实际应用试验和调查的证据。
Semin Arthritis Rheum. 2016 Feb;45(4 Suppl):S18-21. doi: 10.1016/j.semarthrit.2015.11.007. Epub 2015 Dec 2.
4
Efficacy and safety of diclofenac sodium 2% topical solution for osteoarthritis of the knee: a randomized, double-blind, vehicle-controlled, 4 week study.2%双氯芬酸钠 topical 溶液治疗膝骨关节炎的疗效和安全性:一项随机、双盲、赋形剂对照、为期 4 周的研究。 (注:这里“topical”常见释义为“局部的” ,在医学语境中,“topical solution”可译为“局部溶液” ,但可能“外用溶液”更符合习惯表述,不过因需严格按要求翻译,所以保留“topical”未译全)
Curr Med Res Opin. 2016;32(2):241-50. doi: 10.1185/03007995.2015.1113400. Epub 2015 Nov 17.
5
Topical nonsteroidal anti-inflammatory drugs in the treatment of knee osteoarthritis: a systematic review and meta-analysis.局部用非甾体抗炎药治疗膝骨关节炎:系统评价和荟萃分析。
Phys Sportsmed. 2021 Nov;49(4):381-391. doi: 10.1080/00913847.2021.1886573. Epub 2021 Mar 4.
6
Topical therapies in the management of chronic pain.慢性疼痛管理中的局部治疗。
Postgrad Med. 2013 Jul;125(4 Suppl 1):25-33. doi: 10.1080/00325481.2013.1110567111.
7
Topical therapies for osteoarthritis.骨关节炎的局部治疗。
Drugs. 2011 Jul 9;71(10):1259-79. doi: 10.2165/11592550-000000000-00000.
8
Topical nonsteroidal anti-inflammatory drugs for osteoarthritis.局部用非甾体抗炎药治疗骨关节炎。
Postgrad Med. 2010 Nov;122(6):98-106. doi: 10.3810/pgm.2010.11.2227.
9
Topical therapies for knee osteoarthritis.膝关节骨关节炎的局部治疗。
Postgrad Med. 2018 Sep;130(7):607-612. doi: 10.1080/00325481.2018.1505182. Epub 2018 Aug 29.
10
Tolerability of topical diclofenac sodium 1% gel for osteoarthritis in seniors and patients with comorbidities.1%双氯芬酸钠凝胶用于老年骨关节炎患者及合并症患者的耐受性
Am J Geriatr Pharmacother. 2012 Feb;10(1):47-60. doi: 10.1016/j.amjopharm.2011.12.002. Epub 2012 Jan 20.